@article{e9f89650a5b6448bb2eaea30362f1309,
title = "Cancer research: Past, present and future",
abstract = "Research into cancer over the past 10 years has diverged enormously, partly based on the large number of new technologies that are now at our finger tips. With areas of cancer research so disparate, it is not always easy to identify where the next new findings and therapies might come from. With this in mind, we asked four leading cancer researchers from around the world what, in their opinion, we have learnt over the past 10 years and how we should progress in the next 10 years.",
author = "Ya Cao and Depinho, {Ronald A.} and Matthias Ernst and Karen Vousden",
note = "Funding Information: Ya Cao is the Vice Director of the Cancer Research Institute of Xiangya School of Medicine, Central South University and the Dean of the Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Changsha, Hunan, China. She worked as a visiting scientist on six occasions at the National Cancer Institute at Frederick, Maryland, USA, between 1989 and 1997. She is involved in many of the grant-awarding bodies in China, including the National Natural Science Foundation, the State Key Development Program for Basic Research in China and the China Medical Board. Her research focuses on the mechanism and biological importance of the Epstein–Barr virus (EBV) encoded latent membrane protein 1 (LMP1) and whether targeting LMP1 can improve the response of EBV-driven nasopharyngeal carcinoma (NPC) to radiotherapy. Her research also focuses on the epigenetic changes in NPC that is driven by EBV infection.",
year = "2011",
month = oct,
doi = "10.1038/nrc3138",
language = "English (US)",
volume = "11",
pages = "749--754",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "10",
}